Tags » Channing J. Der

Merck's ERK inhibitor shows promise in combo against resistant cancers

by Amirah Al Idrus |

Feb 22, 2018 


One-fifth of patients in a phase 1 study responded to an investigational ERK inhibitor from Merck, bolstering hopes that this type of drug could be used effectively in combination with other cancer drugs. 392 more words

Channing J. Der

Dr. Der Keynote Speaker at UNC Charlotte 4th Annual Biological Sciences Symposium

On May 4, Dr. Der was the keynote speaker at the 4th Annual Biological Sciences Symposium at UNC Charlotte.  This event was sponsored by the Association of Biological Sciences Graduate Students (ABSGS) at the University of North Carolina at Charlotte.   14 more words

Channing J. Der